CRN Daily Supplement

Dr. Andrea Wong honored by ASNF + Mister offers industry perspective in support of HR 841 during briefing with bill sponsor

McKinsey & Company's new survey shows that a rise in consumer interest and purchasing power presents opportunities across markets, particularly as spending on personal wellness rebounds. Plus, a new white paper explores reasons membership in CRN provides PE firms with "insurance" on their investments, including business networking opportunities and introductions.

CRN President & CEO Steve Mister shared insights on what's ahead for dietary supplement regulation during a panel discussion at the Food and Drug Law Institute's (FDLI) annual conference this week. The discussion centered around calls to revamp DSHEA and strengthen FDA’s ability to regulate the supplement category. Plus, IADSA update on EU Titanium dioxide ban imminent and U.S. legislative update on HSA/FSA & CBD bills.

“CRN has a unique understanding and depth of knowledge on age restriction proposals,” CRN Government Relations State Subcommittee Chair Ingrid Lebert of Pharmavite noted. “CRN’s team is careful to respectfully engage those stakeholders we aim to educate, which takes strategic relationship building to ensure an open dialogue..."

Stay updated with CRN's daily member newsletter.

Claims linking synthetic colors with possible attention deficit disorder/hyperactivity are not scientifically sound enough to warrant confusing and costly warning labels, industry stakeholders stated in pushback against new California legislation.

Learn how to leverage NMI's data to chart your pathway for growth—The nutritional supplement industry is always dynamic and, while this past year could even be called turbulent, steady growth drivers can help direct the pathway for growth.

The Dietary Supplement Quality Collaborative (DSQC) will aggressively pursue legislative action from Congress to better protect consumers and monitor industry practices that increase transparency in the supplement marketplace. As DSQC steering committee chair, Pharmavite VP & General Counsel, Christine Burdick-Bell pointed to the value of mandatory product listing in achieving these goals in a recent Whole Foods Magazine byline.

Hemp-derived cannabinoids' existing uses in the U.S. are without regulatory precedent, making a precedent-setting solution necessary for their lawful use as dietary ingredients, CRN's Steve Mister explained in the article, available to HBW Insights subscribers here

Did you know there are almost 400,000 vascular plants on earth (that we know of), not including algae or fungus? Of those 400,000 there are about 2,000 "Herbs of Commerce" traded. Do you know how many of these the lab you use are capable of testing? Labs with fully flexible scope designations such as Alkemist Labs, an ISO/IEC 17025:2017 Accredited Laboratory, with capabilities to test all plants are rare. Learn more in this CRN Associate Member Spotlight edition.